C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
- Resource Type
- Source
- Blood Advances. 6:6071-6074
- Subject
Thrombotic Microangiopathies Neoplasms Humans Antineoplastic Agents Hematology - Language
- ISSN
- 2473-9537
2473-9529